Search results
Results from the WOW.Com Content Network
The General Pharmaceutical Council (GPhC) is the body responsible for the independent regulation of the pharmacists, pharmacy technicians and pharmacy premises within England, Scotland and Wales. It was created in September 2010 when the functions of the body then responsible for regulation and professional representation, the Royal ...
The Patient Information Advisory Group (PIAG) was established in the United Kingdom under section 61 [1] of the Health and Social Care Act 2001 [2] and the Patient Information Advisory Group (Establishment) Regulations 2001 [3] to provide advice on issues of national significance involving the use of patient information and to oversee arrangements created under section 60 [4] of the Act.
Some areas of NIGB functions (d) and (e) above had been delegated to the NIGB's Ethics and Confidentiality Committee (ECC). These functions primarily related to applications to use identifiable patient information without consent, in specific circumstances within the bounds of section 251 of the NHS Act 2006.
Moreover, as far as patient health records are concerned, there are always potential threats of information leakages, data hacking, information destruction, manipulation or even blackmailing of patients by the external or internal users. Since the consequences of Information leaks are comparatively high in contrast to information alterations ...
With the Internet, patients are able to ask for medical advice and treatment, yet issues regarding confidentiality and legal issues come up. [20] Ultimately, emails between a physician and patient are supposed to be used as a supplement for face to face interactions, not for casual messages.
Right to confidentiality, human dignity and privacy: Doctors should observe strict confidentiality of a patient's condition, with the only exception of potential threats to public health. In case of a physical inspection by a male doctor on a female patient, the latter has the right to have a female person present throughout the procedure.
Another ethical challenge of therapeutic privilege which is discussed by Finnerty, is the question of who is qualified to judge the effect of non-disclosure on a patient which is critical consideration for a decision, ‘Insofar as it could be, what was clear from the case law was that it is the medical professional’s judgement of the effect ...
The Clinical Practice Research Datalink will provide researchers with access to safeguarded data that respects patient confidentiality. This will give valuable insights into serious health conditions and ultimately help reduce the time it takes to develop new treatments." [10] The GPRD became part of the data services provision from CPRD.